Key facts
- Abyss Ingredients’s last known valuation is $2.2M (Jan 2026).
- It has raised $3.8M; the latest was Later Stage VC ($590K) in Jan 2026.
- Notable investors include GO Capital, Banque Populaire Grand Ouest, Mer Invest.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Abyss Ingredients
- ·The full record, as it builds
Funding rounds
No funding rounds for Abyss Ingredients are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Abyss Ingredients
Developer of natural health ingredients designed to evaluate marine by-products, combining innovation, circular economy, and sustainability. The company's ingredients are extracted from sustainable marine bio-resources and are scientifically proven with a focus on healthy aging, enabling nutraceutical and nutri-cosmetic companies to develop efficient and differentiating products to meet and exceed their clients' expectations regarding health and well-being.
- Sector
- Healthcare
- HQ
- Caudan, France
- Founded
- 2004
- Employees
- 18
- Website
- abyss-ingredients.com/
- Ownership
- Privately Held (backing)
Abyss Ingredients doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Abyss Ingredients shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Abyss Ingredients in its N-PORT filings yet. We sweep new filings monthly.